Pharmaceutical company uniQure announced new executive appointments to its leadership team and nominations to its board of directors, including the promotion of Christian Klemt from global controller to chief accounting officer. These actions further uniQure’s expansion in the United States and add additional expertise in gene therapy research, development, operations, manufacturing and commercial readiness, the company stated.
